Turn promising projects into investable spin-offs

You have groundbreaking research. We provide the strategic framework, commercial insight, and execution discipline that turns promising projects into investment-ready spin-offs with sustainable trajectories.

How we work with innovation centers

Innovation centers play a critical role in translating world-class science into new ventures. The transition from research project to investable spin-off is a pivotal stage that requires dedicated venture leadership, commercial judgment, and execution structure.

We work alongside innovation centers to strengthen spin-offs at this strategic decision-making stage, embedding hands-on leadership and execution discipline to help promising projects progress confidently toward funding and market entry.

Venture definition

Shape scientific projects into venture-ready concepts, defining the clinical need, product profile, and early assessment of the commercial potential.

Interim early leadership

Serve as interim leadership in the earliest stage, working alongside the inventor and the management team, translating science into strategy, and helping structure the new venture.

Inventor–investor alignment

Bridge inventors and investors, giving both sides clarity and confidence on feasibility, pathway, and the ability to reach value inflection.

Embedded business structure

Embed business and strategic expertise in the first months, providing founders structure, decision support, and a clear execution framework.

Investor-focused de-risking

De-risk the areas investors challenge most: technical readiness, regulatory classification, evidence strategy, IP/FTO, go-to-market and team & governance.

Milestones and funding logic

Create a coherent, investor-ready case with milestones and timelines in which the use-of-funds is fully grounded in practical, achievable development steps.

Early market and capital readiness

Support early engagement with investors and partners, preparing the spin-off to enter the market or raise capital with credibility.

Is your spin-off ready for investment?

Investors evaluate spin-offs against specific criteria. We help you systematically address each of these areas before approaching funders.

Clear clinical or operational need with defined market size

check

Differentiated technology with defensible IP position

check

Experienced founding team or identified leadership pathway

check

Early validation evidence (prototype, user testing, pilot data)

check

Realistic regulatory pathway and timeline

check

Defined product profile and development plan

check

Credible go-to-market strategy with accessible early adopters

check

Milestone-driven roadmap tied to value inflection points

check

Structured governance and decision-making framework

check

Clear use-of-funds aligned to achievable development steps

check

Partner with entrepreneurs who've been where you are

check

Interim CEO or COO leadership for early-stage spin-offs

check

Strategic oversight across multiple projects and portfolio

check

Systematic de-risking of technical, regulatory, and commercial concerns

check

Investor-ready milestone plans and development roadmaps

check

Direct connections to life science investors across Europe and the US

Let's talk